Company announcement – No. 2 / 2021
Continue reading here:
Zealand Pharma announces directed issue and private placement corresponding to approx. 10% of existing share capital
NEW YORK, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that an analyst note commenting on the listing of Intercept’s product on the U.S. Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) website reached a conclusion regarding the status of a newly identified safety signal (NISS) for Ocaliva® (obeticholic acid) that the Company believes is incorrect.
View post:
Intercept Company Statement on Analyst Note
MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results on Wednesday, February 10, 2021, at 4:30pm Eastern Time.
Read the original:
Pacific Biosciences of California, Inc. Fourth Quarter 2020 Financial Results Call
The ' Poultry Healthcare Products market' research report now available at MarketStudyReport.com delivers a thorough analysis of the industry trends influencing the global business scenario. In addition, the report offers definitive information pertaining to the commercialization aspects, revenue estimation, and market size of the industry. The report overtly defines the status of key players in the competitive landscape while including their portfolio and geographical expansion endeavors.
The latest research report on Poultry Healthcare Products market organizes updates pertaining to the growth catalysts, challenges, and opportunities that will define the industry growth over the forecast duration. In addition, it charts the course that business owners should take to address the changes brought in by the Covid-19 pandemic.
Request a sample Report of Poultry Healthcare Products Market at:https://www.marketstudyreport.com/request-a-sample/2545485?utm_source=algosonline.com&utm_medium=AG
Our analysts project that Poultry Healthcare Products market will register a CAGR of XX% over the forecast period 2020-2025.
Moreover, detailed analysis of each regional market as well as insights on the major players that occupy them are highlighted. Individual assessment of the industry segmentation and factors influencing their growth are extensively discussed for a stronger realization of top revenue prospects.
Market snapshot:
Regional outlook:
Product terrain outline:
Application spectrum overview:
Ask for Discount on Poultry Healthcare Products Market Report at:https://www.marketstudyreport.com/check-for-discount/2545485?utm_source=algosonline.com&utm_medium=AG
Competitive landscape summary:
Highlights of the Report:
For More Details On this Report: https://www.marketstudyreport.com/reports/global-poultry-healthcare-products-market-growth-status-and-outlook-2020-2025
Some of the Major Highlights of TOC covers:
Chapter 1: Methodology & Scope
Definition and forecast parameters
Methodology and forecast parameters
Data Sources
Chapter 2: Executive Summary
Business trends
Regional trends
Product trends
End-use trends
Chapter 3: Poultry Healthcare Products Industry Insights
Industry segmentation
Industry landscape
Vendor matrix
Technological and innovation landscape
Chapter 4: Poultry Healthcare Products Market, By Region
Chapter 5: Company Profile
Business Overview
Financial Data
Product Landscape
Strategic Outlook
SWOT Analysis
Related Reports:
2. Global Cutaneous Fibrosis Treatment Market Growth (Status and Outlook) 2021-2026 Cutaneous Fibrosis Treatment Market report covers the market landscape and its growth prospects over the coming years, the Report also brief deals with the product life cycle, comparing it to the relevant products from across industries that had already been commercialized details the potential for various applications, discussing about recent product innovations and gives an overview on potential regional market. Read More: https://www.marketstudyreport.com/reports/global-cutaneous-fibrosis-treatment-market-growth-status-and-outlook-2021-2026
Contact Us: Corporate Sales, Market Study Report LLC Phone: 1-302-273-0910 Toll Free: 1-866-764-2150 Email: [emailprotected]
See the original post here:
Poultry Healthcare Products Market Share, Growth, Statistics, by Application, Production, Revenue & Forecast to 2025 - AlgosOnline
Overview for Stem Cells Market Helps in providing scope and definitions, Key Findings, Growth Drivers, and Various Dynamics.
Stem Cells Market Data and Acquisition Research Study with Trends and Opportunities 2019-2024 The study of Stem Cells market is a compilation of the market of Stem Cells broken down into its entirety on the basis of types, application, trends and opportunities, mergers and acquisitions, drivers and restraints, and a global outreach. The detailed study also offers a board interpretation of the Stem Cells industry from a variety of data points that are collected through reputable and verified sources. Furthermore, the study sheds a lights on a market interpretations on a global scale which is further distributed through distribution channels, generated incomes sources and a marginalized market space where most trade occurs.
Along with a generalized market study, the report also consists of the risks that are often neglected when it comes to the Stem Cells industry in a comprehensive manner. The study is also divided in an analytical space where the forecast is predicted through a primary and secondary research methodologies along with an in-house model.
Download PDF Sample of Stem Cells Market report @ https://hongchunresearch.com/request-a-sample/117744
Key players in the global Stem Cells market covered in Chapter 4: Bio-Rad Laboratories MEDIPOST Miltenyi Biotec Pluristem Therapeutics STEMCELL Technologies Becton, Dickinson and Company Holostem Terapie Avanzate Merck Group Cellular Dynamics International Lonza Group Thermo Fisher Scientific Anterogen Osiris Therapeutics Takara Bio Group Pharmicell
In Chapter 11 and 13.3, on the basis of types, the Stem Cells market from 2015 to 2026 is primarily split into: Adult Stem Cell Human Embryonic Stem Cell Induced Pluripotent Stem Cell Rat Neural Stem Cell Other
In Chapter 12 and 13.4, on the basis of applications, the Stem Cells market from 2015 to 2026 covers: Regenerative Medicine Drug Discovery and Development
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13: North America (Covered in Chapter 6 and 13) United States Canada Mexico Europe (Covered in Chapter 7 and 13) Germany UK France Italy Spain Russia Others Asia-Pacific (Covered in Chapter 8 and 13) China Japan South Korea Australia India Southeast Asia Others Middle East and Africa (Covered in Chapter 9 and 13) Saudi Arabia UAE Egypt Nigeria South Africa Others South America (Covered in Chapter 10 and 13) Brazil Argentina Columbia Chile Others Regional scope can be customized
For a global outreach, the Stem Cells study also classifies the market into a global distribution where key market demographics are established based on the majority of the market share. The following markets that are often considered for establishing a global outreach are North America, Europe, Asia, and the Rest of the World. Depending on the study, the following markets are often interchanged, added, or excluded as certain markets only adhere to certain products and needs.
Here is a short glance at what the study actually encompasses: Study includes strategic developments, latest product launches, regional growth markers and mergers & acquisitions Revenue, cost price, capacity & utilizations, import/export rates and market share Forecast predictions are generated from analytical data sources and calculated through a series of in-house processes.
However, based on requirements, this report could be customized for specific regions and countries.
Brief about Stem Cells Market Report with [emailprotected]https://hongchunresearch.com/report/stem-cells-market-size-2020-117744
Some Point of Table of Content:
Chapter One: Report Overview
Chapter Two: Global Market Growth Trends
Chapter Three: Value Chain of Stem Cells Market
Chapter Four: Players Profiles
Chapter Five: Global Stem Cells Market Analysis by Regions
Chapter Six: North America Stem Cells Market Analysis by Countries
Chapter Seven: Europe Stem Cells Market Analysis by Countries
Chapter Eight: Asia-Pacific Stem Cells Market Analysis by Countries
Chapter Nine: Middle East and Africa Stem Cells Market Analysis by Countries
Chapter Ten: South America Stem Cells Market Analysis by Countries
Chapter Eleven: Global Stem Cells Market Segment by Types
Chapter Twelve: Global Stem Cells Market Segment by Applications 12.1 Global Stem Cells Sales, Revenue and Market Share by Applications (2015-2020) 12.1.1 Global Stem Cells Sales and Market Share by Applications (2015-2020) 12.1.2 Global Stem Cells Revenue and Market Share by Applications (2015-2020) 12.2 Regenerative Medicine Sales, Revenue and Growth Rate (2015-2020) 12.3 Drug Discovery and Development Sales, Revenue and Growth Rate (2015-2020)
Chapter Thirteen: Stem Cells Market Forecast by Regions (2020-2026) continued
Check [emailprotected] https://hongchunresearch.com/check-discount/117744
List of tables List of Tables and Figures Table Global Stem Cells Market Size Growth Rate by Type (2020-2026) Figure Global Stem Cells Market Share by Type in 2019 & 2026 Figure Adult Stem Cell Features Figure Human Embryonic Stem Cell Features Figure Induced Pluripotent Stem Cell Features Figure Rat Neural Stem Cell Features Figure Other Features Table Global Stem Cells Market Size Growth by Application (2020-2026) Figure Global Stem Cells Market Share by Application in 2019 & 2026 Figure Regenerative Medicine Description Figure Drug Discovery and Development Description Figure Global COVID-19 Status Overview Table Influence of COVID-19 Outbreak on Stem Cells Industry Development Table SWOT Analysis Figure Porters Five Forces Analysis Figure Global Stem Cells Market Size and Growth Rate 2015-2026 Table Industry News Table Industry Policies Figure Value Chain Status of Stem Cells Figure Production Process of Stem Cells Figure Manufacturing Cost Structure of Stem Cells Figure Major Company Analysis (by Business Distribution Base, by Product Type) Table Downstream Major Customer Analysis (by Region) Table Bio-Rad Laboratories Profile Table Bio-Rad Laboratories Production, Value, Price, Gross Margin 2015-2020 Table MEDIPOST Profile Table MEDIPOST Production, Value, Price, Gross Margin 2015-2020 Table Miltenyi Biotec Profile Table Miltenyi Biotec Production, Value, Price, Gross Margin 2015-2020 Table Pluristem Therapeutics Profile Table Pluristem Therapeutics Production, Value, Price, Gross Margin 2015-2020 Table STEMCELL Technologies Profile Table STEMCELL Technologies Production, Value, Price, Gross Margin 2015-2020 Table Becton, Dickinson and Company Profile Table Becton, Dickinson and Company Production, Value, Price, Gross Margin 2015-2020 Table Holostem Terapie Avanzate Profile Table Holostem Terapie Avanzate Production, Value, Price, Gross Margin 2015-2020 Table Merck Group Profile Table Merck Group Production, Value, Price, Gross Margin 2015-2020 Table Cellular Dynamics International Profile Table Cellular Dynamics International Production, Value, Price, Gross Margin 2015-2020 Table Lonza Group Profile Table Lonza Group Production, Value, Price, Gross Margin 2015-2020 Table Thermo Fisher Scientific Profile Table Thermo Fisher Scientific Production, Value, Price, Gross Margin 2015-2020 Table Anterogen Profile Table Anterogen Production, Value, Price, Gross Margin 2015-2020 Table Osiris Therapeutics Profile Table Osiris Therapeutics Production, Value, Price, Gross Margin 2015-2020 Table Takara Bio Group Profile Table Takara Bio Group Production, Value, Price, Gross Margin 2015-2020 Table Pharmicell Profile Table Pharmicell Production, Value, Price, Gross Margin 2015-2020 Figure Global Stem Cells Sales and Growth Rate (2015-2020) Figure Global Stem Cells Revenue ($) and Growth (2015-2020) Table Global Stem Cells Sales by Regions (2015-2020) Table Global Stem Cells Sales Market Share by Regions (2015-2020) Table Global Stem Cells Revenue ($) by Regions (2015-2020) Table Global Stem Cells Revenue Market Share by Regions (2015-2020) Table Global Stem Cells Revenue Market Share by Regions in 2015 Table Global Stem Cells Revenue Market Share by Regions in 2019 Figure North America Stem Cells Sales and Growth Rate (2015-2020) Figure Europe Stem Cells Sales and Growth Rate (2015-2020) Figure Asia-Pacific Stem Cells Sales and Growth Rate (2015-2020) Figure Middle East and Africa Stem Cells Sales and Growth Rate (2015-2020) Figure South America Stem Cells Sales and Growth Rate (2015-2020) Figure North America Stem Cells Revenue ($) and Growth (2015-2020) Table North America Stem Cells Sales by Countries (2015-2020) Table North America Stem Cells Sales Market Share by Countries (2015-2020) Figure North America Stem Cells Sales Market Share by Countries in 2015 Figure North America Stem Cells Sales Market Share by Countries in 2019 Table North America Stem Cells Revenue ($) by Countries (2015-2020) Table North America Stem Cells Revenue Market Share by Countries (2015-2020) Figure North America Stem Cells Revenue Market Share by Countries in 2015 Figure North America Stem Cells Revenue Market Share by Countries in 2019 Figure United States Stem Cells Sales and Growth Rate (2015-2020) Figure Canada Stem Cells Sales and Growth Rate (2015-2020) Figure Mexico Stem Cells Sales and Growth (2015-2020) Figure Europe Stem Cells Revenue ($) Growth (2015-2020) Table Europe Stem Cells Sales by Countries (2015-2020) Table Europe Stem Cells Sales Market Share by Countries (2015-2020) Figure Europe Stem Cells Sales Market Share by Countries in 2015 Figure Europe Stem Cells Sales Market Share by Countries in 2019 Table Europe Stem Cells Revenue ($) by Countries (2015-2020) Table Europe Stem Cells Revenue Market Share by Countries (2015-2020) Figure Europe Stem Cells Revenue Market Share by Countries in 2015 Figure Europe Stem Cells Revenue Market Share by Countries in 2019 Figure Germany Stem Cells Sales and Growth Rate (2015-2020) Figure UK Stem Cells Sales and Growth Rate (2015-2020) Figure France Stem Cells Sales and Growth Rate (2015-2020) Figure Italy Stem Cells Sales and Growth Rate (2015-2020) Figure Spain Stem Cells Sales and Growth Rate (2015-2020) Figure Russia Stem Cells Sales and Growth Rate (2015-2020) Figure Asia-Pacific Stem Cells Revenue ($) and Growth (2015-2020) Table Asia-Pacific Stem Cells Sales by Countries (2015-2020) Table Asia-Pacific Stem Cells Sales Market Share by Countries (2015-2020) Figure Asia-Pacific Stem Cells Sales Market Share by Countries in 2015 Figure Asia-Pacific Stem Cells Sales Market Share by Countries in 2019 Table Asia-Pacific Stem Cells Revenue ($) by Countries (2015-2020) Table Asia-Pacific Stem Cells Revenue Market Share by Countries (2015-2020) Figure Asia-Pacific Stem Cells Revenue Market Share by Countries in 2015 Figure Asia-Pacific Stem Cells Revenue Market Share by Countries in 2019 Figure China Stem Cells Sales and Growth Rate (2015-2020) Figure Japan Stem Cells Sales and Growth Rate (2015-2020) Figure South Korea Stem Cells Sales and Growth Rate (2015-2020) Figure Australia Stem Cells Sales and Growth Rate (2015-2020) Figure India Stem Cells Sales and Growth Rate (2015-2020) Figure Southeast Asia Stem Cells Sales and Growth Rate (2015-2020) Figure Middle East and Africa Stem Cells Revenue ($) and Growth (2015-2020) continued
About HongChun Research: HongChun Research main aim is to assist our clients in order to give a detailed perspective on the current market trends and build long-lasting connections with our clientele. Our studies are designed to provide solid quantitative facts combined with strategic industrial insights that are acquired from proprietary sources and an in-house model.
Contact Details: Jennifer Gray Manager Global Sales + 852 8170 0792 [emailprotected]
NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.
As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.
Go here to read the rest:
Impact Of Covid 19 On Stem Cells Industry 2020 Market Challenges, Business Overview And Forecast Research Study 2026 Murphy's Hockey Law - Murphy's...
Parkinsons disease treatment Market unveils a succinct analysis of the market size, regional spectrum and revenue forecast about the Parkinsons disease treatment market. Furthermore, the report points out major challenges and the latest growth plans embraced by key manufacturers that constitute the competitive spectrum of this business domain.
Global Parkinsons disease treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027
Get Sample Copy of The Report@https://brandessenceresearch.com/requestSample/PostId/62
Scope of Market Reports
Parkinsons disease is a neuro degenerative disorder in which parts of the brain become progressively damaged over many years. It is a type of movement disorder. It occurs when nerve tissue unable to produce a chemical named Dopamine which is used to send signals that help you move your body. Parkinsons disease usually developed for aged people i.e. above 60 years, but it can also start earlier. It is more common in men than in women. The cause of Parkinsons disease is unknown, but researchers think that both genetic and environmental factors are involved. Primary symptoms include tremors, Stiffness, Slowness, impaired balance, mild memory & Thinking problem and shuffling gait. Secondary symptoms include Anxiety, Depression, Fatigue, Low blood pressure, muscle cramp, Speech & communication problem, skin & Dental Problem and Dizziness, and Dementia. Risk of Parkinsons disease increases with age and the disease mainly affects person over 50 years of age. The development of Parkinsons disease and the degree of destruction differ from person to person. Many people with Parkinsons disease live long productive lives, whereas others become disabled much more quickly. As symptoms worsen, it may become difficult to walk, talk, and complete simple tasks. Malnutrition and weight maintenance is common problem for people with Parkinsons disease. There is no test to diagnose Parkinsons disease with certainty. Treatment options include medication or surgical treatment. Combination of Levodopa with carbidopa is considered as a gold standard for symptomatic treatment of Parkinsons disease. Surgical treatment options include deep brain stimulation and Carbidopa/levodopa enteral suspension therapy but surgical therapy is effective only for patients who have previously responded to Levodopa therapy. Commercially available drugs for treatment of Parkinsons disease are Sinemet, Safinamide, Rotigotine, Ropinirole, Pramiprexol, Amantidine, Cycloset, Parlodel (Bromocriptine Mesylate), Rytary, Azilect, Northera, Stalevo, Comtess/Comtan and others. More than past decade, huge improvement has been made in the treatment of Parkinsons disease such as identification of new therapeutic targets through genetic research, understanding the common mutations that contribute to Parkinsons disease etc.
Global Parkinsons diseases Treatment Market report is segmented on the basis of Medication, Medical devices, End user, Distribution Channels and Geography. Based on Medication Global Parkinsons disease Treatment Market is classified into Dopamine Precursors, Peripheral Decarboxylase Inhibitors, COMT (Catechol-O-methyltransferase) Inhibitors, MAO (Monoamine Oxidase), Inhibitors and Others (anticholinergics, antihistaminics etc.)
On the basis of Medical Devices Global Parkinsons disease Treatment Market is classified into Deep Brain Stimulation (DBS) Devices, Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices and others. On the basis of End User Global Parkinsons disease Treatment Market is classified into Hospitals, Homecare setting, Clinics and Others. On the basis of Distribution Channel Global Parkinsons disease Drug Market is classified into Retail Pharmacies, Online Pharmacies, Hospital Pharmacies and Drug Stores.
The regions covered in Global Parkinsons diseases Treatment Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Market Dynamics
Global Parkinsons disease Treatment Market is mainly driven by growing prevalence of Parkinsons disease and government funding for research on Parkinsons disease. The increase in number of geriatric population and technological advancements such as combination therapies for prolong action of continuous dopaminergic stimulation drugs, gene therapy, neural transplantation are few other causes which are possible to boost the Parkinsons disease Treatment market. However some restraints like availability of alternative treatments is expected to hold back market and expiry of patents for several drugs such as Stalevo, Azilect, Rytary, Comtan etc. can cause the termination of Parkinsons disease Treatment market. High cost of treatment such as 14.4 Billion USD and lack of expertise for early diagnosis is likely to restrict the market growth.
Also lack of novel and successful therapies in the market to reduce the risk of mortality restraints for this market. The opportunities for Global Parkinsons disease Treatment market includes upcoming technologies like surface EMG (Electromyography) sensors, Pulse oximetry sensors, development in personalized medicine along with huge investment in anti-Parkinsons drugs research will boost the global Parkinsons disease Treatment market. Also development of novel drugs and combination therapy with less side effects and better survival rates is expected to increase the global Parkinsons disease Treatment market.
Get Methodology of Report @https://brandessenceresearch.com/requestMethodology/PostId/62
Europe is likely to achieve the largest share of the global Parkinsons disease treatment market, which is expected to be followed by North America with a sizeable market share. High knowledge about the treatment, increase in expenditure for Research & Development, favorable medicinal reimbursement regulations and policies, the high occurrence of Parkinsons disease, the rapidly growing geriatric population and potential medical pipeline products are likely to contribute to the major share of Europe in Global Parkinsons disease treatment market. The global Parkinsons disease treatment market in the Asia Pacific is anticipated to develop at a profitable rate. The market share of the global Parkinsons disease treatment market is to be expected to grasp by China and Japan in the Asia Pacific, due to the large population of elderly people who are affected with Parkinsons disease.
Furthermore, increase in awareness of disease and government initiatives for improving health care facilities are expected to boost the regional market to a certain extent.
By Medication Analysis Dopamine Precursor, Peripheral Decarboxylase Inhibitors, COMT (Catechol-O-methyltransferase) Inhibitors, MAO(monoamine oxidase) Inhibitors, Others (anticholinergics, antihistaminics etc.)
By Medical Devices Analysis Deep Brain Stimulation (DBS) Devices, Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Others
By End User Analysis Hospitals, Clinics, Homecare setting, Others
By Distribution Channel Retail Pharmacies, Online Pharmacies, Hospital Pharmacies, Drug Store
North America, US, Mexico, Chily, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa
Get Full Report :@https://brandessenceresearch.com/chemical-materials/parkinsons-disease-treatment-market
Related Report @https://www.prnewswire.com/news-releases/at-19-71cagr-zero-trust-security-market-size-is-projected-to-reach-94-35-billion-by-2027says-brandessence-market-research-301213906.html
About Us:
Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us atsales@industrystatsreport.com
Website:https://brandessenceresearch.com/
Article:https://businessstatsnews.com
Blog:http://www.dailyindustrywatch.com
Blog:https://technologyindustrynews.com
Cancers of squamous cells present in the linings of larynx, throat, nose, salivary glands, lips, mouth are collectively called as head and neck cancers. According to World Health Organization (WHO), globally more than 550,000 new cases of head and neck cancer are diagnosed per year with around 300,000 deaths annually. Head and neck cancer is the sixth most common type of cancer and accounts for 56% of all cancers. Treatment of head and neck cancer presents a significant challenge to physicians as the choice of treatment varies from patient to patient and location of the tumor. Head and neck cancers ate often treated with surgery, but the complexity of facial structures and functions limits the surgical treatments.
Request to Sample report @https://www.persistencemarketresearch.com/samples/11734
Surgery for head and neck cancer changes some of the functions such as chewing, swallowing, talking, etc. Surgical therapy in combination with radiation therapy is the most preferred treatment regime by physicians. However, currently available treatment options for head and neck cancer do not result in improvement in survival rate, and head and neck cancer survival rate has decreased from 80% to 50%in last ten years. Recent developments in advanced chemotherapy and radiotherapy allow preserving some of the functions of the face. The introduction of targeted molecular therapy such as gene therapy, monoclonal antibodies, antibody drug conjugates, etc. has opened up huge potential for the growth of head and neck cancer therapeutics market.
Growing incidence of head and neck cancer and demand for cost-effective treatment options are the factors driving the growth of global head and neck cancer therapeutic market. According to Globocan 2012, globally, 521,983 new cases of the lip, oral cavity, and larynx cancer were diagnosed in 2012. Advancements in technology and development of new targeted molecules are believed to play the crucial role in the growth of global head and neck cancer therapeutics market over the forecast period.
Request PMR insights on measuring the impact of COVID-19 coronavirus across industries.
The global market for anti-neoplastic agents is segmented on basis of treatment type, disease indication, end user and geography:
Based on treatment type, global head and neck cancer therapeutics market has been segmented as follow:
Based on disease indication, global head and neck cancer therapeutics market has been segmented as follow:
Based on end user, global head and neck cancer therapeutics market has been segmented as follow:
Increasing smoking rate, tobacco consumption and incidence of HPV-caused cancers are the factors primarily responsible for growing prevalence of head and neck cancers such as oral cavity cancer, nasopharyngeal cancer, etc. Based on treatment type, global head and neck cancer therapeutics market is classified as chemotherapy, radiation therapy, and surgery. Surgery is expected to lead the global market for head and neck cancer therapeutics over the forecast period as it is the choice of therapy by physicians. Radiation therapy is used to prevent the recurrence of cancer and is expected to contribute second largest share in the global head and neck cancer therapeutics market. Chemotherapy is used as an adjunct to other therapies and thus hold little share in global head and neck cancer therapeutics market.
Based on disease indication, global head and neck cancer therapeutics market has been segmented into laryngeal cancer, lip and oral cavity cancer, nasopharyngeal cancer, oropharyngeal cancer, salivary gland cancer and others. Lip and oral cavity cancer indication type segment is expected to contribute the highest share in the global market for head and neck cancer therapeutics market owing to the high global prevalence of cancer. GLOBOCAN 2012 reports_bk_01_01_2020 the highest prevalence of 3.1% in 2012 affecting 467,157 people affected by lip and oral cancer globally.
Based on the end user, the global head and neck cancer therapeutics market has been segmented into hospitals, specialty clinics, and ambulatory surgical centers. Hospital end user segment is anticipated to contribute the maximum share among end users.
Request For TOC @https://www.persistencemarketresearch.com/toc/11734
Based on the regional presence, global head and neck cancer therapeutics market is segmented into five key regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. North America will continue to dominate the global head and neck cancer therapeutics market for due to high prevalence HPV-induced cancers and high smoking rate. Europe is expected to hold second largest market share in global head and neck cancer therapeutics market.
Some of the major players operating in the global head and neck cancer therapeutics market are,
For in-depth competitive analysis, buy [emailprotected]https://www.persistencemarketresearch.com/checkout/11734
Explore Extensive Coverage of PMR`s
Life Sciences & Transformational HealthLandscape
About us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Contact us:
Naved Beg Persistence Market Research Address 305 Broadway, 7th Floor, New York City, NY 10007 United States U.S. Ph. +1-646-568-7751 USA-Canada Toll-free +1 800-961-0353 Sales[emailprotected] Websitehttps://www.persistencemarketresearch.com
See the rest here:
The Head And Neck Cancer Therapeutics Market to shirk economic slowdown between 2016 and 2024 Murphy's Hockey Law - Murphy's Hockey Law
PHOENIX, Jan. 20, 2021 /PRNewswire/ --Creative Medical Technology Holdings, Inc.(OTC: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to Urology, Neurology and Orthopedics, today announced that it will be partnering with Dr. Naveen Kella (MD) exclusively in the Austin, TX region to provide CaverStem to patients suffering from Erectile Dysfunction (ED).
This announcement comes on the heels of a successful launch in San Antonio where Dr. Naveen Kella negotiated his initial exclusive. "I was looking for an alternative for my patients suffering from ED that were not getting results from the traditional therapies, said Dr. Kella. "After I read the publication results of CaverStem in Journal of Translational Medicine, I knew this would be a promising option for my patients. After having treated several dozen patients, I can now confidently say our expertise with Caverstem is a great asset for my practice in San Antonio, TX and I am excited to offer it to patients in the Austin, TX region starting immediately."
The results seen in Dr. Kella's practice are consistent with those seen in the initial trial and post-market surveillance. Patients are seeing drastic improvement in their erections (both the ability to get erect and stay erect) with no adverse results reported.
"We are thrilled to expand our partnership with Dr. Kella into the Austin, TX region", said Timothy Warbington, President and CEO of Creative Medical Technology Holdings Inc. "It's always a nice validation to have one of our existing providers see such positive results that they want to increase their partnership. Despite the strong headwinds we faced due to COVID locking up the health system, we are encouraged by the success stories that continue to pour in from healthcare providers and patients from around the country. We expect to expand our footprint rapidly in 2021 with several doctors in holding pattern waiting for vaccine before expanding their practices."
CaverStem Practices in Partnership with Dr. Naveen Kella:
InVita Clinics - NEW
6012 W William Cannon Dr
Suite B101, Austin TX 78749
Phone: 210-996-2120
The Urology Place
9618 Huebner,
Suite 120 San Antonio, TX 78240
Phone: (210) 617-3670
About Dr. Naveen Kella:
Dr. Naveen Kellais board certified in urology, with a fellowship in Urologic Oncology and robotic surgery. He is known for his experience in treating prostate cancer and has performed over 2,500 robotic prostate cancer surgeries. Literature notes the best surgeons usually have a superior experience. Dr. Kella is the most experienced robotic prostate surgeon in San Antonio and South Texas. In fact, he is one of the most experienced in the nation. Dr. Kella is also an Adjunct Assistant Professor for the UT Health Science Center.
About Erectile Dysfunction:
Erectile dysfunction (ED) is characterized by the lack of ability to achieve and maintain penile erection for intercourse. Methods used to quantify ED include the Erectile Function Visual Analog Scale (EF-VAS) and the International Index of Erectile Function (IIEF-5), however clinically it is primarily diagnosed based on symptomology. In our aging society, ED is becoming an increasing problem. According to one study 39% of men at age 40 experience symptoms of ED, whereas by age 70 the incidence rises to 67%. In this latter age group, it is believed that 50-85% of ED cases are associated with hypertension, diabetes, cardiovascular disease and dyslipidemia. Overall, it is estimated that 10-30 million Americans suffer from this condition.
About Creative Medical Technology Holdings
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company specializing in stem cell technology in the fields of urology, neurology and orthopedics and trades on the OTCQB under the ticker symbol CELZ. For further information about the company, please visit http://www.creativemedicaltechnology.com.
Forward Looking Statements
OTC Markets has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming clinical trials and laboratory results, marketing efforts, funding, etc. Forward-looking statements address future events and conditions and, therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at http://www.sec.gov.
View original content to download multimedia:http://www.prnewswire.com/news-releases/leading-urologist-doubles-down-on-caverstem-regenerative-stem-cell-procedure-for-treatment-of-erectile-dysfunction-in-men-301211452.html
SOURCE Creative Medical Technology Holdings, Inc.
See the original post:
Leading Urologist Doubles Down on CaverStem Regenerative Stem Cell Procedure for Treatment of Erectile Dysfunction in Men - BioSpace
The report attempts to offer high-quality and accurate analysis of the Global Stem Cell Reconstructive Market, keeping in view about the current market scenario as COVID 19 is greatly impacting overall world economy. It also focuses on competitive intelligence, and technological risks and advancements, and other important subjects. Its carefully shaped market intelligence allows market participants to understand the most significant developments in the global Stem Cell Reconstructive market. This helps to understand about the crucial opportunities as well as threats that can impact market globally as world economy has great impact due to COVID 19. The research study also provides deep geographical analysis.
Major Market Players with an in-depth analysis:
Request Free Sample Copy of Stem Cell Reconstructive Market Research Report@ https://www.zealinsider.com/report/89651/stem-cell-reconstructive-market#sample
The report includes a detailed segmentation study of the market. Additionally, segments are analyzed in terms of market growth, share, growth rate, and other vital factors. It also provides the attractiveness index of segments so that players can be informed about lucrative revenue pockets. The extensive evaluation of segments provided in the report will help readers to focus on the right areas of the global Stem Cell Reconstructive market.
Global Stem Cell Reconstructive Market: Product analysis:
Global Stem Cell Reconstructive Market: Application analysis:
Key questions answered in this research study
Any query? Enquire Here For Discount (COVID-19 Impact Analysis Updated Sample): https://www.zealinsider.com/report/89651/stem-cell-reconstructive-market#inquiry
The report assesses the strengths and weaknesses of competitors using competitive analysis tools. In the report, It also provides comprehensive production and shipment analysis from point of origin to end user purchase. Furthermore, latest industry developments have been included to help users stay ahead of their competitors. Apart from the production share of regional markets analyzed in the report, readers are informed about gross margin, price, revenue, and production growth rate of Stem Cell Reconstructive market.
The analysts explore critical influence factors, market drivers, challenges, risk factors, opportunities, and market trends of Stem Cell Reconstructive market to give holistic view on Stem Cell Reconstructive Market.
Buy single user with discounted price now: https://www.zealinsider.com/checkout?reportId=89651&&usert=su
Follow is the chapters involved in Stem Cell Reconstructive Market:
Chapter 1 Stem Cell Reconstructive Market Overview Chapter 2 Executive Summary Chapter 3 Stem Cell Reconstructive Segment by Types (Product Technology) Chapter 4 Global Stem Cell Reconstructive Segment by Application Chapter 5 Global Stem Cell Reconstructive Market by Regions (2015-2027) Chapter 6 Global Stem Cell Reconstructive Market Competition by Manufacturers Chapter 7 Company (Top Players) Profiles and Key Data Chapter 8 Global Stem Cell Reconstructive Revenue by Regions (2015-2020) Chapter 9 Global Stem Cell Reconstructive Revenue by Types Chapter 10 Global Stem Cell Reconstructive Market Analysis by Application Chapter 11 North America Stem Cell Reconstructive Market Development Status and Outlook Chapter 12 Europe Stem Cell Reconstructive Market Development Status and Outlook Chapter 13 Asia Pacific Stem Cell Reconstructive Market Development Status and Outlook Chapter 14 South America Stem Cell Reconstructive Market Development Status and Outlook Chapter 15 Middle East & Africa Stem Cell Reconstructive Market Development Status and Outlook Chapter 16 Stem Cell Reconstructive Manufacturing Cost Analysis Chapter 17 Marketing Strategy Analysis, Distributors/ Traders Chapter 18 Global Stem Cell Reconstructive Market Forecast (2020-2027) Chapter 19 Research Findings and Conclusion
About Us:
We at Zeal Insider aim to be global leaders in qualitative and predictive analysis as we put ourselves in the front seat for identifying worldwide industrial trends and opportunities and mapping them out for you on a silver platter. We specialize in identifying the calibers of the markets robust activities and constantly pushing out the areas which allow our clientele base in making the most innovative, optimized, integrated and strategic business decisions in order to put them ahead of their competition by leaps and bounds. Our researchers achieve this mammoth of a task by conducting sound research through many data points scattered through carefully placed equatorial regions.
Contact Us: Zeal Insider 1st Floor, Harikrishna Building, Samarth Nagar, New Sanghvi, Pune- 411027 India tel: +91-8149441100 (GMT Office Hours) tel: +17738002974 sales@zealinsider.com
Stem Cell Therapy Market: Snapshot
Of late, there has been an increasing awareness regarding the therapeutic potential of stem cells for management of diseases which is boosting the growth of the stem cell therapy market. The development of advanced genome based cell analysis techniques, identification of new stem cell lines, increasing investments in research and development as well as infrastructure development for the processing and banking of stem cell are encouraging the growth of the global stem cell therapy market.
Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1787
One of the key factors boosting the growth of this market is the limitations of traditional organ transplantation such as the risk of infection, rejection, and immunosuppression risk. Another drawback of conventional organ transplantation is that doctors have to depend on organ donors completely. All these issues can be eliminated, by the application of stem cell therapy. Another factor which is helping the growth in this market is the growing pipeline and development of drugs for emerging applications. Increased research studies aiming to widen the scope of stem cell will also fuel the growth of the market. Scientists are constantly engaged in trying to find out novel methods for creating human stem cells in response to the growing demand for stem cell production to be used for disease management.
It is estimated that the dermatology application will contribute significantly the growth of the global stem cell therapy market. This is because stem cell therapy can help decrease the after effects of general treatments for burns such as infections, scars, and adhesion. The increasing number of patients suffering from diabetes and growing cases of trauma surgery will fuel the adoption of stem cell therapy in the dermatology segment.
Global Stem Cell Therapy Market: Overview
Also called regenerative medicine, stem cell therapy encourages the reparative response of damaged, diseased, or dysfunctional tissue via the use of stem cells and their derivatives. Replacing the practice of organ transplantations, stem cell therapies have eliminated the dependence on availability of donors. Bone marrow transplant is perhaps the most commonly employed stem cell therapy.
Osteoarthritis, cerebral palsy, heart failure, multiple sclerosis and even hearing loss could be treated using stem cell therapies. Doctors have successfully performed stem cell transplants that significantly aid patients fight cancers such as leukemia and other blood-related diseases.
Global Stem Cell Therapy Market: Key Trends
The key factors influencing the growth of the global stem cell therapy market are increasing funds in the development of new stem lines, the advent of advanced genomic procedures used in stem cell analysis, and greater emphasis on human embryonic stem cells. As the traditional organ transplantations are associated with limitations such as infection, rejection, and immunosuppression along with high reliance on organ donors, the demand for stem cell therapy is likely to soar. The growing deployment of stem cells in the treatment of wounds and damaged skin, scarring, and grafts is another prominent catalyst of the market.
On the contrary, inadequate infrastructural facilities coupled with ethical issues related to embryonic stem cells might impede the growth of the market. However, the ongoing research for the manipulation of stem cells from cord blood cells, bone marrow, and skin for the treatment of ailments including cardiovascular and diabetes will open up new doors for the advancement of the market.
To get Incredible Discounts on this Report, Click Here @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=1787
Global Stem Cell Therapy Market: Market Potential
A number of new studies, research projects, and development of novel therapies have come forth in the global market for stem cell therapy. Several of these treatments are in the pipeline, while many others have received approvals by regulatory bodies.
In March 2017, Belgian biotech company TiGenix announced that its cardiac stem cell therapy, AlloCSC-01 has successfully reached its phase I/II with positive results. Subsequently, it has been approved by the U.S. FDA. If this therapy is well- received by the market, nearly 1.9 million AMI patients could be treated through this stem cell therapy.
Another significant development is the granting of a patent to Israel-based Kadimastem Ltd. for its novel stem-cell based technology to be used in the treatment of multiple sclerosis (MS) and other similar conditions of the nervous system. The companys technology used for producing supporting cells in the central nervous system, taken from human stem cells such as myelin-producing cells is also covered in the patent.
Global Stem Cell Therapy Market: Regional Outlook
The global market for stem cell therapy can be segmented into Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America emerged as the leading regional market, triggered by the rising incidence of chronic health conditions and government support. Europe also displays significant growth potential, as the benefits of this therapy are increasingly acknowledged.
Asia Pacific is slated for maximum growth, thanks to the massive patient pool, bulk of investments in stem cell therapy projects, and the increasing recognition of growth opportunities in countries such as China, Japan, and India by the leading market players.
Global Stem Cell Therapy Market: Competitive Analysis
Several firms are adopting strategies such as mergers and acquisitions, collaborations, and partnerships, apart from product development with a view to attain a strong foothold in the global market for stem cell therapy.
Some of the major companies operating in the global market for stem cell therapy are RTI Surgical, Inc., MEDIPOST Co., Ltd., Osiris Therapeutics, Inc., NuVasive, Inc., Pharmicell Co., Ltd., Anterogen Co., Ltd., JCR Pharmaceuticals Co., Ltd., and Holostem Terapie Avanzate S.r.l.
Request For TOC @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1787
About TMR Research:
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Contact:
TMR Research, 3739 Balboa St # 1097, San Francisco, CA 94121 United States
Tel: +1-415-520-1050
Read more here:
Stem Cell Therapy Market to Witness Increase in Revenues by 2025 NeighborWebSJ - NeighborWebSJ